Pfizer
Chronic Obstructive Pulmonary Disease Treatment Market Set for Explosive Rise by 2025 with Top Key Players like GSK, Pfizer, Merck
Chronic Obstructive Pulmonary Disease is a common respiratory disease characterized by inflammation of the airways, which results in difficulty in breathing. The disease affects adults, children, and the geriatric population across the globe. The report on the global Chronic Obstructive Pulmonary Disease Treatment market is a complete overview of the market, covering various aspects product […]
Increasing Demand of Gaucher Disease Treatment Market by 2025 with Top Key Players like Abbott, Aptalis Pharma, Genzyme Corporation, Pfizer, Shire Human Genetic Therapies, Eli Lilly and Company, Enobia Pharma, Anthera Pharmaceuticals
Gaucher disease is recessive gene dominance disorder with massive clinical heterogeneity. Symptoms of the disease include painless splenomegaly, anemia, or thrombocytopenia, chronic fatigue, hepatomegaly, bone pain, and pathologic fractures. The lack of drugs in last stage of development is anticipated to limit the expansion of the Gaucher disease market, although the rise in number of […]
Prescription Dermatological Drugs Market 2019 – Huge Growth Opportunities and Expansion by 2025 | Johnson & Johnson, Merck, Bayer, Mylan Pharmaceuticals, Pfizer, Allergan, Valeant Pharmaceuticals, Allergan Inamed Corporation
Skin is the largest organ of the body and the first point of contact for microbes and toxins. It contains a rich habitat of microbes which results in various dysfunctions. This is where dermatology steps in. Dermatological disorders differ across the globe based on geographic location, climatic conditions, socioeconomic status, lifestyles, age, gender, heredity, and […]